Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 8/2019

01-12-2019 | Pancreatoduodenostomy | How-I-Do-It article

Pancreatic resection for cancer—the Heidelberg technique

Authors: Martin Schneider, Oliver Strobel, Thilo Hackert, Markus W. Büchler

Published in: Langenbeck's Archives of Surgery | Issue 8/2019

Login to get access

Abstract

Background

Pancreatic cancer is associated with high recurrence rates, and any surgery should aim to prevent local recurrence. However, systematic resection of putatively tumor-infiltrated soft tissue adjacent to the celiac branches and superior mesenteric artery has not regularly been applied in pancreatic head resection.

Objective

We describe a technique of vessel-oriented pancreatic head resection, allowing for extended removal of lymphatic and neural tissue that is situated in the TRIANGLE in between the celiac trunk, the superior mesenteric artery, and the portal vein.

Conclusions

Vessel-oriented dissection or vascular resection facilitates complete removal of putatively tumor-infiltrated soft tissue, thus potentially reducing the risk of isolated local recurrence in pancreatic cancer.
Literature
1.
go back to reference Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482CrossRef Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479–1482CrossRef
2.
go back to reference Hohenberger W et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Color Dis 11(4):354–364 discussion 364-5CrossRef Hohenberger W et al (2009) Standardized surgery for colonic cancer: complete mesocolic excision and central ligation—technical notes and outcome. Color Dis 11(4):354–364 discussion 364-5CrossRef
3.
go back to reference Kiehlmann M, Weber K, Göhl J, Fietkau R, Agaimy A, Hohenberger W, Merkel S (2016) The impact of surgical quality on prognosis in patients undergoing rectal carcinoma surgery after preoperative chemoradiation. Int J Color Dis 31(2):247–255CrossRef Kiehlmann M, Weber K, Göhl J, Fietkau R, Agaimy A, Hohenberger W, Merkel S (2016) The impact of surgical quality on prognosis in patients undergoing rectal carcinoma surgery after preoperative chemoradiation. Int J Color Dis 31(2):247–255CrossRef
4.
go back to reference Gasparini G et al (2019) Nerves and pancreatic cancer: new insights into a dangerous relationship. Cancers (Basel) 11(7):E893CrossRef Gasparini G et al (2019) Nerves and pancreatic cancer: new insights into a dangerous relationship. Cancers (Basel) 11(7):E893CrossRef
5.
go back to reference Verbeke CS, Gladhaug IP (2012) Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg 99(8):1036–1049CrossRef Verbeke CS, Gladhaug IP (2012) Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg 99(8):1036–1049CrossRef
6.
go back to reference Groot VP et al (2018) Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg 267(5):936–945CrossRef Groot VP et al (2018) Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg 267(5):936–945CrossRef
7.
go back to reference Strobel O et al (2013) Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20(3):964–972CrossRef Strobel O et al (2013) Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol 20(3):964–972CrossRef
8.
go back to reference Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, Jones O, Palmer DH, Cox TF, Smith CJ, O'Reilly DA, Izbicki JR, Scarfe AG, Valle JW, McDonald A, Carter R, Tebbutt NC, Goldstein D, Padbury R, Shannon J, Dervenis C, Glimelius B, Deakin M, Anthoney A, Lerch MM, Mayerle J, Oláh A, Rawcliffe CL, Campbell F, Strobel O, Büchler MW, Neoptolemos JP, European Study Group for Pancreatic Cancer (2019) The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Ann Surg 269(3):520–529CrossRef Ghaneh P, Kleeff J, Halloran CM, Raraty M, Jackson R, Melling J, Jones O, Palmer DH, Cox TF, Smith CJ, O'Reilly DA, Izbicki JR, Scarfe AG, Valle JW, McDonald A, Carter R, Tebbutt NC, Goldstein D, Padbury R, Shannon J, Dervenis C, Glimelius B, Deakin M, Anthoney A, Lerch MM, Mayerle J, Oláh A, Rawcliffe CL, Campbell F, Strobel O, Büchler MW, Neoptolemos JP, European Study Group for Pancreatic Cancer (2019) The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Ann Surg 269(3):520–529CrossRef
9.
go back to reference Hank T, Hinz U, Tarantino I, Kaiser J, Niesen W, Bergmann F, Hackert T, Büchler MW, Strobel O (2018) Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. Br J Surg 105(9):1171–1181CrossRef Hank T, Hinz U, Tarantino I, Kaiser J, Niesen W, Bergmann F, Hackert T, Büchler MW, Strobel O (2018) Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail. Br J Surg 105(9):1171–1181CrossRef
10.
go back to reference Strobel O et al (2017) Pancreatic cancer surgery: the new R-status counts. Ann Surg 265(3):565–573CrossRef Strobel O et al (2017) Pancreatic cancer surgery: the new R-status counts. Ann Surg 265(3):565–573CrossRef
11.
go back to reference Jones, R.P., et al., Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial. JAMA Surg, 2019. Jones, R.P., et al., Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: a secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial. JAMA Surg, 2019.
12.
go back to reference Tjaden C et al (2016) Clinical impact of structured follow-up after pancreatic surgery. Pancreas 45(6):895–899CrossRef Tjaden C et al (2016) Clinical impact of structured follow-up after pancreatic surgery. Pancreas 45(6):895–899CrossRef
13.
go back to reference Hackert T, Sachsenmaier M, Hinz U, Schneider L, Michalski CW, Springfeld C, Strobel O, Jäger D, Ulrich A, Büchler MW (2016) Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg 264(3):457–463CrossRef Hackert T, Sachsenmaier M, Hinz U, Schneider L, Michalski CW, Springfeld C, Strobel O, Jäger D, Ulrich A, Büchler MW (2016) Locally advanced pancreatic cancer: neoadjuvant therapy with folfirinox results in resectability in 60% of the patients. Ann Surg 264(3):457–463CrossRef
14.
go back to reference Klaiber U, Leonhardt CS, Strobel O, Tjaden C, Hackert T, Neoptolemos JP (2018) Neoadjuvant and adjuvant chemotherapy in pancreatic cancer. Langenbeck's Arch Surg 403(8):917–932CrossRef Klaiber U, Leonhardt CS, Strobel O, Tjaden C, Hackert T, Neoptolemos JP (2018) Neoadjuvant and adjuvant chemotherapy in pancreatic cancer. Langenbeck's Arch Surg 403(8):917–932CrossRef
15.
go back to reference Strobel O, Neoptolemos J, Jäger D, Büchler MW (2019) Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol 16(1):11–26CrossRef Strobel O, Neoptolemos J, Jäger D, Büchler MW (2019) Optimizing the outcomes of pancreatic cancer surgery. Nat Rev Clin Oncol 16(1):11–26CrossRef
16.
go back to reference Del Chiaro M et al (2015) Cattel-Braasch maneuver combined with artery-first approach for superior mesenteric-portal vein resection during pancreatectomy. J Gastrointest Surg 19(12):2264–2268CrossRef Del Chiaro M et al (2015) Cattel-Braasch maneuver combined with artery-first approach for superior mesenteric-portal vein resection during pancreatectomy. J Gastrointest Surg 19(12):2264–2268CrossRef
17.
go back to reference Hackert T, Werner J, Weitz J, Schmidt J, Büchler MW (2010) Uncinate process first—a novel approach for pancreatic head resection. Langenbeck's Arch Surg 395(8):1161–1164CrossRef Hackert T, Werner J, Weitz J, Schmidt J, Büchler MW (2010) Uncinate process first—a novel approach for pancreatic head resection. Langenbeck's Arch Surg 395(8):1161–1164CrossRef
18.
go back to reference Weitz J, Rahbari N, Koch M, Büchler MW (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg 210(2):e1–e4CrossRef Weitz J, Rahbari N, Koch M, Büchler MW (2010) The “artery first” approach for resection of pancreatic head cancer. J Am Coll Surg 210(2):e1–e4CrossRef
19.
go back to reference Stauffer JA et al (2009) Aberrant right hepatic arterial anatomy and pancreaticoduodenectomy: recognition, prevalence and management. HPB (Oxford) 11(2):161–165CrossRef Stauffer JA et al (2009) Aberrant right hepatic arterial anatomy and pancreaticoduodenectomy: recognition, prevalence and management. HPB (Oxford) 11(2):161–165CrossRef
20.
go back to reference Heye T, Zausig N, Klauss M, Singer R, Werner J, Richter GM, Kauczor HU, Grenacher L (2011) CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol 17(9):1126–1134CrossRef Heye T, Zausig N, Klauss M, Singer R, Werner J, Richter GM, Kauczor HU, Grenacher L (2011) CT diagnosis of recurrence after pancreatic cancer: is there a pattern? World J Gastroenterol 17(9):1126–1134CrossRef
21.
go back to reference Adham M, Singhirunnusorn J (2012) Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol 38(4):340–345CrossRef Adham M, Singhirunnusorn J (2012) Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol 38(4):340–345CrossRef
22.
go back to reference Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) Artery-first’ approaches to pancreatoduodenectomy. Br J Surg 99(8):1027–1035CrossRef Sanjay P, Takaori K, Govil S, Shrikhande SV, Windsor JA (2012) Artery-first’ approaches to pancreatoduodenectomy. Br J Surg 99(8):1027–1035CrossRef
23.
go back to reference Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15(6):1651–1660CrossRef Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15(6):1651–1660CrossRef
24.
go back to reference Tummers WS et al (2019) Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 106(8):1055–1065CrossRef Tummers WS et al (2019) Impact of resection margin status on recurrence and survival in pancreatic cancer surgery. Br J Surg 106(8):1055–1065CrossRef
25.
go back to reference Butler JR, Ahmad SA, Katz MH, Cioffi JL, Zyromski NJ (2016) A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford) 18(4):305–311CrossRef Butler JR, Ahmad SA, Katz MH, Cioffi JL, Zyromski NJ (2016) A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma. HPB (Oxford) 18(4):305–311CrossRef
26.
go back to reference Ironside N et al (2018) Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg 105(6):628–636CrossRef Ironside N et al (2018) Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival. Br J Surg 105(6):628–636CrossRef
27.
go back to reference Hirono S et al (2018) Mesenteric approach vs. conventional approach for pancreatic cancer during pancreaticoduodenectomy: study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma. Trials 19(1):613CrossRef Hirono S et al (2018) Mesenteric approach vs. conventional approach for pancreatic cancer during pancreaticoduodenectomy: study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma. Trials 19(1):613CrossRef
28.
go back to reference Hackert T, Strobel O, Michalski CW, Mihaljevic AL, Mehrabi A, Müller-Stich B, Berchtold C, Ulrich A, Büchler MW (2017) The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. HPB (Oxford) 19(11):1001–1007CrossRef Hackert T, Strobel O, Michalski CW, Mihaljevic AL, Mehrabi A, Müller-Stich B, Berchtold C, Ulrich A, Büchler MW (2017) The TRIANGLE operation - radical surgery after neoadjuvant treatment for advanced pancreatic cancer: a single arm observational study. HPB (Oxford) 19(11):1001–1007CrossRef
29.
go back to reference Mitra A, Pai E, Dusane R, Ranganathan P, DeSouza A, Goel M, Shrikhande SV (2018) Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors. Langenbeck's Arch Surg 403(2):203–212 Mitra A, Pai E, Dusane R, Ranganathan P, DeSouza A, Goel M, Shrikhande SV (2018) Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors. Langenbeck's Arch Surg 403(2):203–212
30.
go back to reference Yamamoto KN et al (2017) Personalized management of pancreatic ductal adenocarcinoma patients through computational modeling. Cancer Res 77(12):3325–3335CrossRef Yamamoto KN et al (2017) Personalized management of pancreatic ductal adenocarcinoma patients through computational modeling. Cancer Res 77(12):3325–3335CrossRef
31.
go back to reference Mahajan UM, Langhoff E, Goni E, Costello E, Greenhalf W, Halloran C, Ormanns S, Kruger S, Boeck S, Ribback S, Beyer G, Dombroswki F, Weiss FU, Neoptolemos JP, Werner J, D'Haese JG, Bazhin A, Peterhansl J, Pichlmeier S, Büchler MW, Kleeff J, Ganeh P, Sendler M, Palmer DH, Kohlmann T, Rad R, Regel I, Lerch MM, Mayerle J (2018) Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma. Gastroenterology 155(5):1625–1639 e2CrossRef Mahajan UM, Langhoff E, Goni E, Costello E, Greenhalf W, Halloran C, Ormanns S, Kruger S, Boeck S, Ribback S, Beyer G, Dombroswki F, Weiss FU, Neoptolemos JP, Werner J, D'Haese JG, Bazhin A, Peterhansl J, Pichlmeier S, Büchler MW, Kleeff J, Ganeh P, Sendler M, Palmer DH, Kohlmann T, Rad R, Regel I, Lerch MM, Mayerle J (2018) Immune cell and stromal signature associated with progression-free survival of patients with resected pancreatic ductal adenocarcinoma. Gastroenterology 155(5):1625–1639 e2CrossRef
Metadata
Title
Pancreatic resection for cancer—the Heidelberg technique
Authors
Martin Schneider
Oliver Strobel
Thilo Hackert
Markus W. Büchler
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 8/2019
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-019-01839-1

Other articles of this Issue 8/2019

Langenbeck's Archives of Surgery 8/2019 Go to the issue